早发性脊柱侧凸中磁控生长棒的长度变化行为:一项多中心研究
该多中心前瞻性登记研究分析了189例原发MCGR、44例转换MCGR和41例二次MCGR的早发性脊柱侧凸患者,发现所有队列后续每次延长获得的长度均下降(p < 0.01),二次MCGR组延长能力显著差于原发和转换组(p < 0.02),仅21.7%的棒达到最大行程的80%以内。
要点
- MCGR在早发性脊柱侧凸患者中同样存在「收益递减法则」,后续每次延长获得的长度均下降。
- 二次MCGR组每次后续延长的能力显著差于原发MCGR和转换MCGR组(p < 0.02)。
- 原发MCGR队列中,特发性和神经肌肉性病因的延长长度随时间下降,综合征性EOS保持延长能力。
核心结论
- MCGR在早发性脊柱侧凸患者中经历收益递减法则。
- 仅21.7%的棒扩展至最大行程的80%以内。
研究设计与样本
- 前瞻性收集的多中心登记研究,查询接受MCGR治疗的EOS患者。
- 纳入仅使用脊柱基座植入物且随访至少2年的患者;排除先天性脊柱侧凸、单棒、延长次数<3次或数据缺失>25%的患者。
- 分为3个队列:原发MCGR(pMCGR)首次植入MCGR,二次MCGR(sMCGR)从MCGR转换为新MCGR,转换MCGR(cMCGR)从非MCGR植入物转换为MCGR。
- 共分析189例pMCGR、44例cMCGR和41例sMCGR患者。
主要发现
- 从MCGR置入后至最近随访或确定性手术前,pMCGR组与cMCGR组在主要Cobb角、T1-S1高度或T1-T12高度随时间的变化上无差异。
- 所有队列后续每次延长获得的长度均下降(p < 0.01),sMCGR组每次后续延长的能力显著差于pMCGR和cMCGR组(p < 0.02)。
- 1年生存率pMCGR为90.5%、sMCGR为84.1%、cMCGR为76.4%;2年生存率分别为61.5%、54.4%、41.4%;3年生存率分别为37.6%、36.7%、26.9%。
- 排除仍在扩展的MCGR后,pMCGR中27.6%、sMCGR中8.8%、cMCGR中17.1%达到最大行程;总体21.7%达到最大行程。
- 在pMCGR队列内,特发性和神经肌肉性病因的延长长度随时间下降(p < 0.001),而综合征性EOS保持延长能力(p = 0.51);神经肌肉组随时间延长能力最低( vs 综合征组p = 0.001,vs 特发性组p = 0.02)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The "law of diminishing returns" is described for traditional growing rods. Magnetically controlled growing rods (MCGRs) have become a preferred implant for the surgical treatment of early-onset scoliosis (EOS). We examined a large cohort of patients with EOS to determine whether the law of diminishing returns applies to MCGRs. METHODS: A prospectively collected, multicenter registry was queried for patients with EOS treated with MCGRs. Patients with only spine-based implants and a minimum of 2 years of follow-up were included; patients with congenital scoliosis, single rods, <3 lengthenings, or >25% missing data were excluded. Patients were analyzed in 3 cohorts: primary MCGR (pMCGR) had first-time MCGR implants, secondary MCGR (sMCGR) were converted from an MCGR to a new MCGR, and conversion MCGR (cMCGR) were converted from a non-MCGR implant to MCGR. RESULTS: A total of 189 patients in the pMCGR group, 44 in the cMCGR group, and 41 in the sMCGR group were analyzed. From post-MCGR placement to the most recent follow-up or pre-definitive procedure, there were no differences in the changes in major Cobb angle, T1-S1 height, or T1-T12 height over time between the pMCGR and cMCGR groups. There was a decrease in length achieved at subsequent lengthenings in all cohorts (p < 0.01), and the sMCGR group had a significantly poorer ability to lengthen at each subsequent lengthening versus the pMCGR and cMCGR groups (p < 0.02). The 1-year survival rate was 90.5% for pMCGR, 84.1% for sMCGR, and 76.4% for cMCGR; 2-year survival was 61.5%, 54.4%, and 41.4%, respectively; and 3-year survival was 37.6%, 36.7%, and 26.9%, respectively. Excluding MCGRs still expanding, 27.6% of pMCGRs, 8.8% of sMCGRs, and 17.1% of cMCGRs reached the maximum excursion. Overall, 21.7% reached the maximum excursion. Within the pMCGR cohort, idiopathic and neuromuscular etiologies had a decline in lengthening achieved over time (p < 0.001), while syndromic EOS demonstrated a preserved ability to lengthen over time (p = 0.51). When the etiological groups were compared with each other, the neuromuscular group had the least ability to lengthen over time (p = 0.001 versus syndromic, p = 0.02 versus idiopathic). CONCLUSIONS: The MCGR experiences the law of diminishing returns in patients with EOS. We found that only 21.7% of rods expanded to within 80% of the maximum excursion. LEVEL OF EVIDENCE: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
引用
- Heyer JH, Anari JB, Baldwin KD, et al. Lengthening Behavior of Magnetically Controlled Growing Rods in Early-Onset Scoliosis: A Multicenter Study. J Bone Joint Surg Am. 2022. PMID: 36367763. doi:10.2106/JBJS.22.00483
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。